Ontology highlight
ABSTRACT:
SUBMITTER: Pobiruchin M
PROVIDER: S-EPMC4802671 | biostudies-literature | 2016 Jun
REPOSITORIES: biostudies-literature
Data in brief 20160312
Records of female breast cancer patients were selected from a clinical cancer registry and separated into three cohorts according to HER2-status (human epidermal growth factor receptor 2) and treatment with or without Trastuzumab (a humanized monoclonal antibody). Propensity score matching was used to balance the cohorts. Afterwards, documented information about disease events (recurrence of cancer, metastases, remission of local/regional recurrences, remission of metastases and death) found in ...[more]